Former Sandoz Executive Pleads Guilty in U.S. Price-Fixing Probe

A former senior executive at Novartis AG generics unit Sandoz pleaded guilty on Friday for conspiring to fix prices of generic drugs, the latest in a long-running U.S. criminal antitrust probe.

Hector Armando Kellum, who was responsible for overseeing generic-drug prices and contracts at Sandoz, a New Jersey-based generic and biosimilar company run by the Swiss pharmaceutical giant, pleaded guilty to conspiring with other drug executives to fix prices from 2013 to 2015, the U.S. Justice Department said in a news release on Friday.

Kellum allegedly conspired to set prices and rig bids for off-patent drugs with former Taro Pharmaceutical ...